Nebula Caravel Acquisition Corp. (NASDAQ:NEBC) shareholders have approved its combination with dog-walking app Rover at a special meeting July 28.
The deal was overwhelmingly approved, but Nebula Caravel’s press release and 8-K filing did not reveal redemption figures. The materials noted, however, that the deal would bring $240 million in net proceeds to upon completion and Rover expected at the time of the deal announcement to add $250 million to its balance sheet through the transaction. This would appear to make it one of the smoother votes of the week as the down market has made the de-SPAC endgame difficult for many others.
Nebula Caravel expects to close the deal July 30, after which the combined company’s shares and warrants will commence trading on Nasdaq under the ticker symbols “ROVR” and “ROVRW” August 2.
The parties initially announced the $1.35 billion deal on February 11. Rover connects consumers with local pet-sitters, walkers and groomers via an online marketplace and has thus far facilitated services between 500,000 pet care providers and 2 million pet owners.
Nebula Caravel and Rover joined SPACInsider for a live Q&A webinar on March 31. All other proposals related to the business combination were approved by shareholders. For a full list of proposals and vote tallies, click HERE.
ADVISORS
- Morgan Stanley & Co. LLC is acting as exclusive financial advisor to Rover.
- Wilson Sonsini Goodrich & Rosati is acting as legal advisor to Rover.
- Deutsche Bank Securities acted as lead financial advisor, capital markets advisor and private placement agent to Nebula Caravel Acquisition Corp.
- William Blair & Co., LLC and Stifel Financial Corp., also acted as capital markets advisor and private placement agents to Nebula Caravel Acquisition Corp.
- Simpson Thacher & Bartlett LLP is acting as legal advisor to Caravel.
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...
Trump Media (NASDAQ:DJT) is down about -15% in the pre-market following the filing of its first S-1 since closing its combination with Digital World, and this includes the issuance of the 21,491,251 shares. Of these, 14,375,000 are to be made available for those exercising warrants while the rest would go out to note holders from...
At the SPAC of Dawn This week, bookended by the end of Ramadan and the beginning of Passover, could wind up stacked with events to avoid those holiday times, but for now SPACs have scheduled just six extension votes for this stretch. Redwood (NASDAQ:RWOD) and Genesis Growth Tech (OTC:GGAAF) have yet to release results from...